SCIENTIFIC GAMES CORP's ticker is SGMS and the CUSIP is 80874P109. A total of 205 filers reported holding SCIENTIFIC GAMES CORP in Q1 2021. The put-call ratio across all filers is 0.17 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $189,000 | -20.3% | 4,028 | 0.0% | 0.01% | -10.0% |
Q1 2022 | $237,000 | -19.1% | 4,028 | -8.1% | 0.01% | 0.0% |
Q4 2021 | $293,000 | -42.5% | 4,385 | -28.5% | 0.01% | -37.5% |
Q3 2021 | $510,000 | -5.9% | 6,134 | -12.4% | 0.02% | +23.1% |
Q2 2021 | $542,000 | +47.3% | 7,002 | -26.7% | 0.01% | +44.4% |
Q1 2021 | $368,000 | -73.9% | 9,557 | -71.8% | 0.01% | -70.0% |
Q4 2020 | $1,408,000 | -28.5% | 33,925 | -39.8% | 0.03% | -30.2% |
Q3 2020 | $1,969,000 | +93.8% | 56,400 | -14.2% | 0.04% | +95.5% |
Q2 2020 | $1,016,000 | +916.0% | 65,718 | +535.9% | 0.02% | +1000.0% |
Q1 2020 | $100,000 | -79.1% | 10,334 | -42.1% | 0.00% | -81.8% |
Q4 2019 | $478,000 | +132.0% | 17,843 | +75.9% | 0.01% | +120.0% |
Q3 2019 | $206,000 | +50.4% | 10,141 | +47.0% | 0.01% | +66.7% |
Q2 2019 | $137,000 | +29.2% | 6,900 | +32.7% | 0.00% | +50.0% |
Q1 2019 | $106,000 | -31.6% | 5,200 | -40.1% | 0.00% | -50.0% |
Q4 2018 | $155,000 | -53.6% | 8,675 | +27.7% | 0.00% | -50.0% |
Q2 2018 | $334,000 | – | 6,791 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stone House Capital Management, LLC | 2,700,000 | $180,441,000 | 100.00% |
Fine Capital Partners, L.P. | 9,354,622 | $625,169,000 | 93.28% |
WASHINGTON UNIVERSITY | 1,785,714 | $119,339,000 | 33.42% |
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 714,285 | $47,736,000 | 19.43% |
HARVARD MANAGEMENT CO INC | 2,678,571 | $179,009,000 | 16.80% |
Caledonia (Private) Investments Pty Ltd | 9,282,787 | $620,369,000 | 9.65% |
Perpetual Investment Management Ltd | 746,083 | $49,861,000 | 5.72% |
Eos Focused Equity Management, L.P. | 86,297 | $5,767,000 | 4.49% |
1060 Capital, LLC | 36,327 | $2,428,000 | 3.93% |
Nantahala Capital Management | 1,559,300 | $104,208,000 | 3.67% |